Source:http://linkedlifedata.com/resource/pubmed/id/15868434
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-5-3
|
pubmed:abstractText |
In oestrogen receptor-positive (ER+) breast cancer, HER-2/neu and the progesterone receptor (PR) are inversely associated. This explains a lower response to anti-oestrogens if ER+ breast cancers are HER-2/neu positive. One randomized study however, showed that premenopausal women with an ER+ breast cancer respond to anti-oestrogens independent of HER-2/neu. We therefore hypothesized an age-related association between HER-2/neu and PR in ER+ breast cancers. Receptors for ER, PR and HER-2/neu were analysed by immunohistochemistry (IHC). A uni- and multivariate analyses was carried out to assess this relationship in 1104 women with an ER+ breast cancer. We observed an inverse association between HER-2/neu and PR only after age 45. There were 173 women of age<or=45 and 931 of age>45 years. In multivariate analysis, only tumour grade (p=0.005) but not PR status was associated with HER-2/neu in women age<or=45 years. However, in age>45 years group, both PR status (p=0.001) and tumour grade (p=0.001) were independently associated with HER-2/neu. In ER+ breast cancers from women age>45, PR was positive in 76.9% if HER-2/neu negative but in 53.4% if HER-2/neu positive (p<0.001) and the median quantitative PR levels are 150 and 75 respectively in HER-2/neu negative and HER-2/neu positive tumours (p=0.002). This age effect of HER-2/neu on the PR status was not seen in women age<or=45 years and the median quantitative PR levels are 200 and 220 respectively in HER-2/neu negative and HER-2/neu positive tumours (p=0.518). The study confirms an age-related inverse relationship between HER-2/neu and PR only in women age>45 years but not in women age<or=45 years.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0167-6806
|
pubmed:author |
pubmed-author:AmantFredericF,
pubmed-author:BertelootPatrickP,
pubmed-author:ChristiaensMarie RoseMR,
pubmed-author:DrijkoningenMariaM,
pubmed-author:HuangHuei-JeanHJ,
pubmed-author:NevenPatrickP,
pubmed-author:ParidaensRobertR,
pubmed-author:Van LimbergenErikE,
pubmed-author:VergoteIgnaceI,
pubmed-author:WildiersHansH
|
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15868434-Adult,
pubmed-meshheading:15868434-Aged,
pubmed-meshheading:15868434-Aging,
pubmed-meshheading:15868434-Breast Neoplasms,
pubmed-meshheading:15868434-Female,
pubmed-meshheading:15868434-Humans,
pubmed-meshheading:15868434-Immunohistochemistry,
pubmed-meshheading:15868434-Middle Aged,
pubmed-meshheading:15868434-Multivariate Analysis,
pubmed-meshheading:15868434-Postmenopause,
pubmed-meshheading:15868434-Predictive Value of Tests,
pubmed-meshheading:15868434-Premenopause,
pubmed-meshheading:15868434-Prognosis,
pubmed-meshheading:15868434-Receptor, erbB-2,
pubmed-meshheading:15868434-Receptors, Estrogen,
pubmed-meshheading:15868434-Receptors, Progesterone,
pubmed-meshheading:15868434-Tumor Markers, Biological
|
pubmed:year |
2005
|
pubmed:articleTitle |
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
|
pubmed:affiliation |
Division of Gynaecologic Oncology in Department of Obstetrics and Gynaecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
|
pubmed:publicationType |
Journal Article
|